During the past decade, Fundacao Jose Luiz Egydio Setubal conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacao Jose Luiz Egydio Setubal" are "Influenza A" (2 trials), "Hypertension" (1 trials), "Respiratory Syncytial Virus Infections" (1 trials) and "Respiratory Tract Infections" (1 trials). Many other conditions were trialed in "Fundacao Jose Luiz Egydio Setubal" in a lesser frequency.

Most popular intervention types in "Fundacao Jose Luiz Egydio Setubal" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "Azilsartan Medoxomil High-dose" (1 trials) and "Azilsartan Medoxomil Low-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Jose Luiz Egydio Setubal" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Fundacao Jose Luiz Egydio Setubal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fundacao Jose Luiz Egydio Setubal, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Jose Luiz Egydio Setubal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".